The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Open Access
- 1 April 1990
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 265 (12), 6836-6844
- https://doi.org/10.1016/s0021-9258(19)39224-5
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.JCI Insight, 1989
- Isoelectric and mass characterization of human platelet thromboxane A2/prostaglandin H2 receptorsBiochemical and Biophysical Research Communications, 1989
- A diacylglycerol analogue reduces neuronal calcium currents independently of protein kinase C activationNature, 1989
- Calcium channels in thrombin-activated human platelet membraneNature, 1988
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle.Circulation, 1985
- Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- Thrombin-induced protein phosphorylation in human platelets.JCI Insight, 1975
- Cytochalasin B, the blood platelet release reaction and cyclic GMPNature, 1975
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962